NIJ FY25 Research and Evaluation on Drugs and Crime: Nexus with Firearms and Violence
ID: 358109Type: Posted
Overview

Buyer

National Institute of Justice (USDOJ-OJP-NIJ)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358109

Additional Information

https://nij.ojp.gov/funding/opportunities/o-nij-2025-172321
Timeline
    Description

    The National Institute of Justice (NIJ) is offering a funding opportunity titled "NIJ FY25 Research and Evaluation on Drugs and Crime: Nexus with Firearms and Violence," aimed at supporting rigorous applied research that informs evidence-based practices for law enforcement and criminal justice agencies. This initiative focuses on the intersection of drug-related crimes and firearm offenses, seeking to address issues such as drug trafficking, drug markets, and associated violence through innovative research. The funding, available through a cooperative agreement, ranges from $0 to $2,000,000, with applications due by March 31, 2025. For further assistance, applicants can contact the OJP Response Center at 800-851-3420 or via email at grants@ncjrs.gov.

    Point(s) of Contact
    grants@ncjrs.gov
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Research on Community Level Interventions to Prevent Firearm and Related Violence, Injury and Mortality
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at supporting research on community-level interventions to prevent firearm and related violence, injury, and mortality. This initiative encourages applications that incorporate multiple intervention levels and sectors, such as health, education, and justice, and emphasizes collaboration with communities and organizations. The NIH seeks to adopt a comprehensive approach to understanding the causes of violence and suicide while promoting evidence-based prevention methods. Interested applicants should note that applications are not currently being solicited, but the FOAs are expected to be published in December 2022, with funding anticipated to begin in fiscal year 2022. For further inquiries, applicants can contact Dr. Dara R. Blachman-Demner at dara.blachman-demner@nih.gov or by phone at 301-496-8522.
    Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses," aimed at enhancing the training of nurse scientists and related fields in firearm injury prevention. This program seeks to develop and implement short courses (ranging from 2 to 12 weeks) that focus on evidence-based interventions, health equity, and the social determinants of firearm injuries, with an emphasis on addressing inequities across various demographics. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and government agencies, particularly those serving historically underrepresented groups, with funding available up to $200,000 per year for a maximum of three years. Applications are due by January 25, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Chemical Countermeasures Research Program (CCRP) Initiative, aimed at supporting research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, such as fentanyl and carfentanil. This initiative seeks to advance understanding of both immediate and delayed health impacts associated with these substances, emphasizing innovative research into toxicity mechanisms and the development of new therapeutic strategies. The program will provide up to four grants, with a maximum award of $300,000 annually over a potential five-year period, totaling an estimated $2 million in funding. Interested applicants, including various educational and nonprofit institutions, must submit their proposals by November 18, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    National Community Anti-Drug Coalition Institute (NCI)
    Office of National Drug Control Policy
    The Office of National Drug Control Policy (ONDCP) is forecasting a grant opportunity titled the National Community Anti-Drug Coalition Institute (NCI), aimed at enhancing the capacity of community coalitions to implement evidence-based substance use prevention interventions. The primary objectives of this grant are to increase the effectiveness of community coalitions across the United States and to strengthen the technical assistance and training provided to these coalitions, particularly during the critical adolescent years when substance use initiation is most prevalent. With an estimated total program funding of $2.5 million and a single award anticipated, eligible applicants include national nonprofit organizations with expertise in community anti-drug coalitions. Interested parties should note that the estimated synopsis post date is December 9, 2024, with a closing date for applications on February 7, 2025, and the expected award date is March 10, 2025. For further inquiries, applicants can contact Helen Hernandez, Assistant Director for Drug Free Communities, at HelenHernandez@ondcp.eop.gov or by phone at 202-395-6665.
    Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Accelerating the Pace of Substance Use Research Using Existing Data." This initiative invites applications that propose innovative analyses of existing social science, behavioral, administrative, and neuroimaging data to investigate the etiology and epidemiology of substance use behaviors and related disorders, including HIV prevention and health service utilization. The program aims to leverage public datasets to enhance understanding of substance use trajectories and effective prevention strategies, particularly focusing on underrepresented populations and health disparities. A total funding commitment of $2 million is available for fiscal year 2026, with applications due by January 25, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanism for Time-Sensitive Substance Use Research" under the National Institute on Drug Abuse (NIDA). This grant, designated as R21, aims to support pilot, feasibility, and exploratory research addressing urgent issues in substance use epidemiology and health services, particularly in response to sudden increases in substance misuse and emerging public health challenges. Eligible applicants include a wide range of entities such as educational institutions, governmental bodies, and nonprofit organizations, with a budget cap of $275,000 over two years. Interested parties must submit their applications by September 9, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity titled "NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity," which aims to support research initiatives that address the intersection of substance use and racial equity. This grant program, utilizing the DP1 activity code, is designed to foster meaningful collaborations and innovative projects in this critical area of health research. With an estimated total program funding of $3.5 million and an award ceiling of $700,000, the anticipated application period will open in Fall 2025, following the expected publication of the notice of funding opportunity in Spring 2025. Interested applicants should prepare to submit their proposals by the estimated closing date of October 14, 2025, with awards expected to be made by July 1, 2026.
    Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents." This initiative aims to support innovative research that utilizes scalable technologies to investigate the cellular responses associated with substance use disorders in rodent models, focusing on integrating neural activity metrics with molecular profiles to enhance understanding of addiction-related neurobehavioral processes. The total funding available is $2 million, with individual grants not exceeding $700,000 in direct costs per year for a project period of up to five years, and proposals must adhere to NIH’s data sharing policies. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for February 23, 2026.
    Research Grants for Preventing Violence and Violence Related Injury (R01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering research grants aimed at preventing violence and violence-related injuries through the initiative titled "Research Grants for Preventing Violence and Violence Related Injury (R01)." This program seeks to fund effectiveness research that evaluates innovative programs, practices, or policies designed to address interpersonal violence and suicide, particularly among youth and young adults aged 10 to 24 years. With an estimated total program funding of $9.6 million, the CDC anticipates awarding approximately eight grants, with individual awards ranging from $0 to $400,000. Interested applicants can reach out to Samantha Case at ncipcerpo@cdc.gov or by phone at 907-271-1569, with applications due by December 1, 2025, and project start dates expected around September 30, 2026.
    Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced the Cutting-Edge Basic Research Awards (CEBRA) aimed at promoting innovative research in the field of substance use disorders (SUDs). This funding opportunity invites exploratory applications that focus on high-risk, high-impact research not currently represented in NIDA’s portfolio, encouraging the development of revolutionary methodologies or the testing of transformative hypotheses. The program seeks to stimulate novel insights into the etiology and treatment of SUDs by integrating diverse scientific disciplines, with a maximum budget of $275,000 for each two-year project, allowing no more than $150,000 to be requested in a single year. Applications are due by February 10, 2025, and the funding opportunity will remain open until August 12, 2027; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.